Ahlfors
UG, Baastrup
PC. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatrica Scandinavica. 1962;64:226–37. [
PubMed: 7324992]
Ahuja
S, Bose
A, Lu
K, Greenberg
W, Németh
G, Laszlovszky
I. A Multicenter, Randomized, double-blind trial to evaluate the effect of cariprazine in bipolar depression. Conference of the International Society for CNS Clinical Trials and Methodology, 3-4 October 2011, Amelia Island, Florida, US.
Altamura
AC, Russo
M, Vismara
S, Mundo
E. Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. Journal of Clinical Psychopharmacology. 2004;24:454–6. [
PubMed: 15232342]
Altamura
AC, Salvadori
D, Madaro
D, Santini
A, Mundo
E. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. Journal of Affective Disorders. 2003;76:267–71. [
PubMed: 12943958]
Amsterdam
JD, Shults
J. Does tachyphylaxis occur after repeated antidepressant exposure in patients with bipolar II major depressive episode?
Journal of Affective Disorders. 2009;115:234–40. [
PubMed: 18694599]
Amsterdam
JD, Luo
L, Shults
J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. American Journal of Psychiatry. 2010;167:792–800. [
PMC free article: PMC2896440] [
PubMed: 20360317]
Amsterdam
JD, Shults
J. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study. International Clinical Psychopharmacology. 2005;20:257–64. [
PubMed: 16096516]
AstraZeneca. Effectiveness of quetiapine XR vs. sertraline in acute bipolar depression as add-on therapy to previous mood stabilizer treatment: a pilot study. NCT00857584/D1443L00058. (Unpublished); 2012a. Available from:
http://clinicaltrials.gov/show/NCT00857584Baastrup
PC, Poulsen
JC, Schou
M, Thomsen
K, Amidsen
A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet. 1970;2:326–30. [
PubMed: 4194439]
Benazzi
F. Improving the Mood Disorder Questionnaire to detect bipolar II disorder. Canadian Journal of Psychiatry. 2003;48:770–01. [
PubMed: 14733459]
Benedetti
F, Barbini
B, Lucca
A, Campori
E, Colombo
C, Smeraldi
E. Sleep deprivation hastens the antidepressant action of fluoxetine. European Archives of Psychiatry and Clinical Neuroscience. 1997;247:100–03. [
PubMed: 9177956]
Berk
M, Dean
OM, Cotton
SM, Gama
CS, Kapczinski
F, Fernandes
B, et al. Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. BMC Medicine. 2012;10:91. [
PMC free article: PMC3482580] [
PubMed: 22891797]
Berk
MC, Copolov
Sl, Dean
O, Lu
K, Jeavons
S, Schapkaitz, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder: a double-blind randomized placebo-controlled trial. Biological Psychiatry. 2008;64:468–75. [
PubMed: 18534556]
Bose
A, Starace
A, Wang
Q, Diaz
E, Goodman
J, Ruth
A, et al. Cariprazine in the treatment of acute mania in bipolar disorder: A double-blind, placebo-controlled, phase III trial. 165th Annual Meeting of the American Psychiatric Association, 5-9 May 2012, Philadelphia, USA.
Bowden
CL, Vieta
E, Ice
KS, Schwartz
JH, Wang
PP, Versavel
M. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. Journal of Clinical Psychiatry. 2010;71:130–7. [
PubMed: 20122373]
Bowden
CL, Singh
V, Weisler
R, Thompson
P, Chang
X, Quinones
M, et al. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatrica Scandinavica. 2012;126:342–50. [
PubMed: 22708645]
Bristol-Myers
Squibb. A 12-week, multicenter, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of adjunctive aripiprazole therapy in the treatment of mania in bipolar I disorder patients treated with valproate or lithium and in need of further clinical improvement. (Unpublished); 2011. Available from:
http://clinicaltrial.gov/ct2/show/NCT00665366Burdick
KE, Braga
RJ, Nnadi
CU, Shaya
Y, Stearns
WH, Malhotra
AK. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: Targeting cognitive dysfunction. Journal of Clinical Psychiatry. 2012;73:103–12. [
PMC free article: PMC4457389] [
PubMed: 22152405]
Calabrese
JR, Suppes
T, Bowden
CL, Sachs
GS, Swann
AC, McElroy
SL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. Journal of Clinical Psychiatry. 2000;61:841–50. [
PubMed: 11105737]
Camuri
G, Dell’Osso
B, Guerrieri
I, Arici
C, Oldani
L, Altamura
AC. Augmentative repetitive transcranial magnetic stimulation (rTMS) in the acute treatment of drug-resistant depression. Abstracts of the 21th European Congress of Psychiatry, 6-9 April 2013, Nice, France. European Psychiatry. 2013;28:S1.
Castelo
MS, Hyphantis
TN, Macêdo
DS, Lemos
GO, Machado
YO, Kapczinski
F, et al. Screening for bipolar disorder in the primary care: a Brazilian survey. Journal of Affective Disorders. 2012;143:118–24. [
PubMed: 22959680]
Chengappa
KN, Levine
J, Gershon
S, Mallinger
AG, Hardan
A, Vagnucci
A
et al. Inositol as an add-on treatment for bipolar depression. Bipolar Disorders. 2000;2:47–55. [
PubMed: 11254020]
Chung
KF, Tso
KC, Chung
RT. Validation of the Mood Disorder Questionnaire in the general population in Hong Kong. Comprehensive Psychiatry. 2009;50:471–6. [
PubMed: 19683618]
Colombo
C, Lucca
A, Benedetti
F, Barbini
B, Campori
E, Smeraldi
E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: Replication of main effects and interaction. Psychiatry Research. 2000;95:43–53. [
PubMed: 10904122]
Costa
RT, Cheniaux
E, Rosaes
PA, Carvalho
MR, Freire
RC, Versiani
M, et al. The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study. Revista Brasileira de Psiquiatria. 2011;33:144–9. [
PubMed: 21829907]
Cundall
RL, Brooks
PW, Murray
LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychological Medicine. 1972;2:308–11. [
PubMed: 4562449]
Das
AK, Olfson
M, Gameroff
MJ, Pilowsky
DJ, Blanco
C, Feder
A, et al. Screening for bipolar disorder in a primary care practice. JAMA: The Journal of the American Medical Association. 2005;293:956–63. [
PubMed: 15728166]
Dashtbozorgi
B, Ghadirian
F, Khajeddin
N, Karam
K. Effect of family psychoeducation on the level of adaptation and improvement of patients with mood disorders. Iranian Journal of Psychiatry and Clinical Psychology. 2009;15:193–200.
de Sousa Gurgel
W, Rebouças
DB, Negreiros de Matos
KJ, Carneiro
AH, Gomes de Matos e Souza
F, Affective Disorders Study Group. Brazilian Portuguese validation of Mood Disorder Questionnaire. Comprehensive Psychiatry. 2012;53:308–312. [
PubMed: 21632039]
Denicoff
KD, Singh
J, Sporn
J, Zarate
CA, Quiroz
JA, Brutsche
NE, et al. Antiglucocorticoid therapy in bipolar depression with mifepristone. Bipolar Disorders. 2005;7:47.
Diazgranados
N, Ibrahim
L, Brutsche
N, Newberg
A, Kronstein
P, Khalife
S, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry. 2010;67;793–802. [
PMC free article: PMC3000408] [
PubMed: 20679587]
Dolberg
O, Dannon
PN, Schreiber
S, Grunhaus
L. Transcranial magnetic stimulation in patients with bipolar depression: A double blind, controlled study. Bipolar Disorders. 2002;4:94–5. [
PubMed: 12479689]
El-Mallakh
RS, Salem
MR, Chopra
AS, Mickus
GJ, Penagaluri
P. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study. International Clinical Psychopharmacology. 2009;24:145–9. [
PubMed: 19367153]
Esparon
J, Kolloori
J, Naylor
GJ, McHarg
AM, Smith
AH, Hopwood
SE. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. British Journal of Psychiatry. 1986;148:723–5. [
PubMed: 3535976]
Fieve, RR, Platman
SR, Plutchik
RH. The use of lithium in affective disorders. I. Acute endogenous depression. The American Journal of Psychiatry. 1968;125:487–91 [
PubMed: 4886102]
Findling
RLK, Kafantaris
V, Pavuluri
M, McNamara
NK, Frazier
JA, Sikich
L, et al. Post-acute effectiveness of lithium in pediatric bipolar I disorder. Journal of Child and Adolescent Psychopharmacology. 2013;23:80–90. [
PMC free article: PMC3609605] [
PubMed: 23510444]
Frangou
SL, Lewis
M, McCrone
P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. British Journal of Psychiatry. 2006;188:46–50. [
PubMed: 16388069]
Freeman
AJ, Youngstrom
EA, Frazier
TW, Youngstrom
JK, Demeter
C, Findling
RL. Portability of a screener for pediatric bipolar disorder to a diverse setting. Psychological Assessment. 2012;24:341–51. [
PMC free article: PMC3495327] [
PubMed: 21942229]
Frey
BN, Simpson
W, Wright
L, Steiner
M. Sensitivity and specificity of the Mood Disorder Questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period. Journal of Clinical Psychiatry. 2012;73:1456–61. [
PubMed: 23146292]
Frye
MA, Ketter
TA, Kimbrell
TA, Dunn
RT, Speer
AM, Osuch
EA, et al. A placebo controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology. 2000;20:607–14. [
PubMed: 11106131]
Furey
ML, Zarate
CA. Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side. Journal of Clinical Psychiatry. 2013;74:850–1. [
PMC free article: PMC5014541] [
PubMed: 24021505]
Gao
K, Kemp
DE, Ganocy
SJ, Muzina
DJ, Xia
G, Findling
RL. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disorders. 2008;10:907–15. [
PubMed: 19594506]
Geller
B, Luby
JL, Joshi
P, Wagner
KD, Emslie
G, Walkup
JT. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry. 2012;69:515–28. [
PMC free article: PMC3581342] [
PubMed: 22213771]
Gindre
CH, Husky
M, Brebant
C, Gay
C, Cuche
H, Swendsen
J. Changes in daily life associated with psychoeducation for bipolar disorder. Annales MedicoPsychologiques. 2009;167:280–4.
Goldberg
JF, Burdick
KE, Endick
CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. American Journal of Psychiatry. 2004;161:564–6. [
PubMed: 14992985]
Graves
RE, Alim
TN, Aigbogun
N, Chrishon
K, Mellman
TA, Charney
DS. Diagnosing bipolar disorder in trauma exposed primary care patients. Bipolar Disorders. 2007;9:318–23. [
PubMed: 17547578]
Grisaru
N, Chudakov
B, Yaroslavsky
Y, Belmaker
RH. Transcranial magnetic stimulation in mania: a controlled study. American Journal of Psychiatry. 1998;155:1608–10. [
PubMed: 9812128]
Himmelhoch
JM, Thase
ME, Mallinger
AG, Houck
P. Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry. 1991;148:910–16. [
PubMed: 2053632]
Hirschfeld
RM, Cass
AR, Holt
DC, Carlson
CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. The Journal of the American Board of Family Practice. 2005;18:233–9. [
PubMed: 15994469]
Jackson
HG, McGorry
PD, Killackey
E, Bendall
S, Allott
K, Dudgeon
P, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychological Medicine. 2008;38:725–35. [
PubMed: 18005494]
Jon
DI, Hong
N, Yoon
BH, Jung
HY, Ha
K, Shin
YC, et al. Validity and reliability of the Korean version of the Mood Disorder Questionnaire. Comprehensive Psychiatry. 2009;50:286–91. [
PubMed: 19374975]
Joshi
G, Petty
C, Wozniak
J, Faraone
SV, Spencer
AE, Woodworth
KY. A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents. Psychopharmacology. 2013;227:449–58. [
PubMed: 23397049]
Kafantaris
V, Coletti
DJ, Dicker
R, Padula
G, Pleak
RR, Alvir
J, et al. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:984–93. [
PubMed: 15266193]
Keck
Jr
PE, Calabrese
JR, McQuade
RD, Carson
WH, Carlson
BX, Rollin
LM
et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. Journal of Clinical Psychiatry. 2006;67:626–37. [
PubMed: 16669728]
Kemp
DE, Hirschfeld
RM, Ganocy
SJ, Elhaj
O, Slembarski
R, Bilali
S, et al. Screening for bipolar disorder in a county jail at the time of criminal arrest. Journal of Psychiatric Research. 2008;42:778–86. [
PMC free article: PMC2475656] [
PubMed: 17935734]
Kessell
A, Holt
NF. A controlled study of a tetracyclic antidepressant - maprotiline (Ludiomil). Medical Journal of Australia. 1975;1:773–6. [
PubMed: 1097869]
Knesevich
M, Wang
Q, Bose
A, Papadakis
K, Starace
A, Thomson
L, Andor
Gy, Németh
G, Laszlovszky
I. Phase II trial cariprazine in acute mania associated with bipolar I disorder: effect across symptoms. 49th Annual New Research Approaches for Mental Health Interventions Meeting, 29 June -2 July, Hollywood, FL; 2009.
Kowatch
RA, Suppes
T, Carmody
TJ, Bucci
JP, Hume
JH, Kromelis
M, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2000;39:713–20. [
PubMed: 10846305]
Kulkarni
JG. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology. 2006;31:543–7. [
PubMed: 16356651]
McElroy
S. Short-and longer-term treatment with lurasidone in patients with bipolar I depression: Effect on metabolic syndrome. Neuropsychopharmacology. 2013;38:S535–S536.
McElroy
SLW. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. International Clinical Psychopharmacology. 2011;26:48–53. [
PubMed: 20861739]
Meyer
TD, Bernhard
B, Born
C, Fuhr
K, Gerber
S, Schaerer
L, et al. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools - going beyond samples of purely mood-disordered patients. Journal of Affective Disorders. 2011;128:291–8. [
PubMed: 20674032]
Miklowitz
DJ, Schneck
CD, Singh
MK, Taylor
DO, George
EL, Cosgrove
VE, et al. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. Journal of the American Academy of Child and Adolescent Psychiatry. 2013;52:121–31. [
PMC free article: PMC3558946] [
PubMed: 23357439]
Murphy
BL, Stoll
AL, Harris
PQ, Ravichandran
C, Babb
SM, Carlezon
WA
Jr
et al. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: A double-blind, randomized add-on clinical trial. Journal of Clinical Psychopharmacology. 2012;32:699–703. [
PubMed: 22926607]
Nierenberg
AA, Friedman
ES, Bowden
CL, Sylvia
LG, Thase
ME, Ketter
T, et al. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. The American Journal of Psychiatry. 2013;170:102–10. [
PubMed: 23288387]
Nierenberg
AA, Ostacher
MJ, Calabrese
JR, Ketter
TA, Marangell
LB, Miklowitz
DJ, et al. Treatment resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol or risperidone. American Journal of Psychiatry. 2006;163:210–6. [
PubMed: 16449473]
Nolen
WA, Kupka
RW, Hellemann
G, Frye
MA, Altshuler
LL, Leverich
GS, et al. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: A failed but clinically useful study. Acta Psychiatrica Scandinavica. 2007;115:360–5. [
PubMed: 17430413]
Norris
ER, Karen
B, Correll
JR, Zemanek
KJ, Lerman
J, Primelo
RA, et al. A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. Journal of Affective Disorders. 2013;144:141–7. [
PubMed: 22963894]
Okuma
T, Inanaga
K, Otsuki
S, Sarai
K, Takahashi
R, Hazama
H, et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology. 1981;73: 95–6 [
PubMed: 6785799]
Osher
Y, Bersudsky
Y, Belmaker
RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. Journal of Clinical Psychiatry. 2005;66:726–9. [
PubMed: 15960565]
Pickett-Schenk
SA, Lippincott
RC, Bennett
C, Steigman
PJ. Improving knowledge about mental illness through family-led education: the journey of hope. Psychiatric Services. 2008;59:49–56. [
PubMed: 18182539]
Praharaj
SK, Ram
D, Arora
M. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study. Journal of Affective Disorders. 2009;117:146–150. [
PubMed: 19178948]
Prasko
J, Latalova
K, Cerna
M, Grambal
A, Jelenova
D, Kamaradova
D, et al. Internet based psychoeducative CBT program for bipolar patients treated with thymostabilisers. Abstracts of the 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France. European Psychiatry. 2013;28.
Preti
A, Rocchi
MB, Sisti
D, Mura
T, Manca
S, Siddi
S, et al. The psychometric discriminative properties of the Peters et al Delusions Inventory: a receiver operating characteristic curve analysis. Comprehensive Psychiatry. 2007;48:62–9. [
PubMed: 17145284]
Sanchez-Moreno
J, Villagran
JM, Gutierrez
JR, Camacho
M, Ocio
S, Palao
D, et al. Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disorders. 2008;10:400–12. [
PubMed: 18402628]
Sachs
GS, Nierenberg
AA, Calabrese
JR, Marangell
LB, Wisniewski
SR, Gyulai
L, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine. 2007;356:1711–22. [
PubMed: 17392295]
Schaffer
LC, Schaffer
CB, Miller
AR, Manley
JL, Piekut
JA, Nordahl
TE. An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder. Journal of Affective Disorders. 2013;147:407–10. [
PubMed: 23040739]
Sheehan
DV, McElroy
SL, Harnett-Sheehan
K, Keck
PE
Jr, Janavs
J, Rogers
J, et al. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. Journal of Affective Disorders. 2009;115:376–85. [
PubMed: 19042026]
Sheehan
DV, Harnett-Sheehan
K, Hidalgo
RB, Janavs
J, McElroy
SL, Amado
D
et al. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. Journal of Affective Disorders. 2013;145:83–94. [
PubMed: 22920718]
Singh
V, Bowden
CL, Mintz
J. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania. International Clinical Psychopharmacology. 2013;28:91–5. [
PubMed: 23238761]
Solomon
DA, Ryan
CE, Keitner
GI, Miller
IW, Shea
MT, Kazim
A, et al. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. Journal of Clinical Psychiatry. 1997;58:95–9. [
PubMed: 9108809]
Speer
AM, Benson
BE, Kimbrell
TK, Wassermann
EM, Willis
MW, Herscovitch
P, et al. Opposite effects of high and low frequency rTMS on mood in depressed patients: Relationship to baseline cerebral activity on PET. Journal of Affective Disorders. 2009;115:386–94. [
PMC free article: PMC2779113] [
PubMed: 19027962]
Stamm
TA, Lewitzka
U, Sauer
C, Pilhatsch
M, Smolka
MN, Koeberle
U, et al. Supraphysiological doses of levothyroxine in bipolar depression: A randomised controlled, double blind study. Journal of Clinical Psychiatry. 2014;75:162–8. [
PubMed: 24345793]
Staring
AB, Van der Gaag
M, Koopmans
GT, Selten
JP, Van Beveren
JM, Hengeveld
MW. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry. 2010;197:448–55. [
PubMed: 21119150]
Stoll
AL, Severus
WE, Freeman
MP, Rueter
S, Zboyan
HA, Diamond
E, et al. Omega-3 Fatty Acids in Bipolar Disorder. Archives of General Psychiatry
1999;56:407–12. [
PubMed: 10232294]
Suppes
T, Webb
A, Paul
B, Carmody
T, Kraemer
H, Rush
AJ. Clinical outcome in a randomised 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry. 1999;156:1164–9. [
PubMed: 10450255]
Szuba
MP, Amsterdam
JD, Fernando
AT
3rd, Gary
KA, Whybrow
PC, Winokur
A. Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression. Journal of Clinical Psychopharmacology. 2005;25:325–30. [
PubMed: 16012274]
Tamayo
JM, Sutton
VK, Mattei
MA, Diaz
B, Jamal
HH, Vieta
E, et al. Effectiveness and safety of the combination of fluoxentine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. Journal of Clinical Psychopharmacology. 2009;29:358–61. [
PMC free article: PMC2797124] [
PubMed: 19593175]
Tohen
M, Calabrese
JR, Sachs
GS, Banov
MD, Detke
HC, Risser
R, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. American Journal of Psychiatry. 2006;163(2):247–56. [
PubMed: 16449478]
Vieta. E, Sánchez-Moreno
J, Bulbena
A, Chamorro
L, Ramos
JL, Artal
J, et al. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). Journal of Affective Disorders. 2007;101:43–55. [
PubMed: 17189651]
Vita
A, De Peri
L, Siracusano
A, Sacchetti
E. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: Meta-analyses of randomized-controlled trials. International Clinical Psychopharmacology. 2013;28:219–27. [
PubMed: 23719049]
Wang
Z, Gao
K, Kemp
DE, Chan
PK, Serrano
MB, Conroy
C, et al. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Psychopharmacology Bulletin. 2010;43:5–21. [
PMC free article: PMC3442254] [
PubMed: 21240149]
Watson
S, Gallagher
P, Porter
RJ, Smith
MS, Herron
LJ, Bulmer
S, et al. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biological Psychiatry. 2012;72:943–9. [
PubMed: 22770649]
Woo
YSB, Bahk
WM, Chung
MY, Kim
DH, Yoon
BH, Lee
JH, et al. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. Human Psychopharmacology. 2011;26:543–53. [
PubMed: 22134973]
Wozniak
J, Mick
E, Waxmonsky
J, Kotarski
M, Hantsoo
L, Biederman
J. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. Journal of Child and Adolescent Psychopharmacology. 2009;19:539–45. [
PubMed: 19877978]
Yang
FD, Li
J, Tan
YL, Chen
DC, Yao
FX, Zhang
XL, et al. Optimized therapeutic scheme and individualized dosage of sodium valproate in patients with bipolar disorder sub-type I. Chinese Journal of New Drugs. 2009;18:47–52.
Yong Ning
Z, Z
Hui. Therapeutic Effect of Mirtazapine Combined with Lithium Carbonate on Bipolar Depression. Chinese Mental Health Journal. 2005;19:492–4.
Young
LT, Joffe
RT, Robb
JC, MacQueen
GM, Marriott
M, Patelis-Siotis
I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. American Journal of Psychiatry. 2000;157:124–6. [
PubMed: 10618026]
Young
AH, Gallagher
P, Watson
S, Del-Estal
D, Owen
BM, Ferrier
IN. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology. 2004;29:1538–45. [
PubMed: 15127079]
Young
RC, Biggs
JT, Ziegler
VE, Meyer
DA. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 1978;133:429–35. [
PubMed: 728692]
Youngstrom
EA, Gracious
BL, Danielson
CK, Findling
RL, Calabrese
J. Toward an integration of parent and clinician report on the Young Mania Rating Scale. Journal of Affective Disorders. 2003;77:179–90. [
PubMed: 14607396]
Youngstrom
EA, Findling
RL, Calabrese
JR, Gracious
BL, Demeter
C, Bedoya
DD, et al. Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:847–58. [
PubMed: 15213586]
Youngstrom
EA, Meyers
O, Demeter
C, Youngstrom
J, Morello
L, Piiparinen
R, et al. Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings. Bipolar Disorders. 2005;7:507–17. [
PubMed: 16403176]
Youngstrom
EA, Van Meter
A, Algorta
GP, Marcinick
H, Freeman
A, Meyers
O, et al. Can we detect bipolar in youths? Diagnostic efficiency of caregiver, youth, and teacher report of manic symptoms in outpatient settings. Neuropsychopharmacology. 2011;36:S420–S421.
Zarate
Jr
CA, Tohen
M. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. American Journal of Psychiatry. 2004;161:169–71. [
PubMed: 14702269]
Zhang
ZJ, Kang
WH, Tan
QR, Li
Q, Gao
CG, Zhang
FG, et al. Adjunctive herbal medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study. Journal of Psychiatric Research. 2007;41:360–9. [
PubMed: 16081106]
Zarate
CA, Payne
JL, Singh
J, Quiroz
JA, Luckenbaugh
DA, Denicoff
KD, et al. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry. 2004;56:54–60. [
PubMed: 15219473]
Zarate
CA
Jr, Brutsche
NE, Ibrahim
L, Franco-Chaves
J, Diazgranados
N, Cravchik
A, et al. Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biological Psychiatry. 2012;71:939–46. [
PMC free article: PMC3343177] [
PubMed: 22297150]
Zimmerman
M, Ruggero
CJ, Galione
JN, McGlinchey
JB, Dalrymple
K, Chelminski
I, et al. Detecting differences in diagnostic assessment of bipolar disorder. Journal of Nervous and Mental Disease. 2010;198:339–42. [
PubMed: 20458195]
